Neuroone Medical Technologies is trading 11.61% lower at $0.99 pre-market on October 12, with no clear company-specific catalyst identified.
- The price compares with the October 9 close of $1.12.
- Recent company news included a Dartmouth research subaward announced October 8 and preliminary fiscal 2026 revenue growth plus a record purchase order reported October 5; neither directly explains this morning’s drop.
- Supplied sector context is positive, while major-index futures are mixed, so available context does not establish a broader-market cause.